Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
Interim Report for the Six Months Ended 31 July 2019 Interim Report for the Six Months Ended 31 July 2019 October 11, 2019 By Dave Gancarz
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks
